Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.975
+0.045 (2.33%)
Sep 2, 2025, 10:19 AM - Market open

Entera Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
907817218120
Upgrade
Market Cap Growth
30.25%351.66%-17.80%-74.05%308.59%-23.76%
Upgrade
Enterprise Value
77711075413
Upgrade
Last Close Price
1.932.120.600.732.811.08
Upgrade
PS Ratio
530.91431.41-156.95141.9154.33
Upgrade
PB Ratio
4.349.661.671.793.592.64
Upgrade
P/TBV Ratio
5.119.661.671.793.592.64
Upgrade
EV/Sales Ratio
466.72394.91-51.0594.5135.56
Upgrade
Debt / Equity Ratio
0.010.030.040.010.010.06
Upgrade
Asset Turnover
0.010.02-0.010.030.03
Upgrade
Quick Ratio
5.897.4710.109.367.934.81
Upgrade
Current Ratio
10.477.6310.329.588.014.95
Upgrade
Return on Equity (ROE)
-82.22%-103.34%-80.30%-76.17%-81.04%-115.46%
Upgrade
Return on Assets (ROA)
-44.56%-56.64%-44.65%-43.06%-42.77%-52.83%
Upgrade
Return on Capital (ROIC)
-50.28%-62.64%-49.13%-48.52%-49.57%-69.25%
Upgrade
Earnings Yield
-12.03%-12.22%-51.42%-62.15%-15.04%-56.56%
Upgrade
FCF Yield
-7.60%-8.73%-42.38%-59.65%-11.21%-53.50%
Upgrade
Buyback Yield / Dilution
-26.34%-29.79%-0.69%-10.23%-41.90%-51.62%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q